M&A
US regulator grants conditional approval to $43-bn ChemChina-Syngenta merger
05 Apr 2017
The US federal regulator yesterday approved the $43-billion merger between State-owned China National Chemical Corporation (ChemChina) and Switzerland's Syngenta AG on condition that it divest three products
Essar sells Aegis to Capital Square Partners
03 Apr 2017
BP sells North Sea Pipeline System to Ineos
03 Apr 2017
Ineos, run by British businessman Jim Ratcliffe, is currently engaged in a $600-million project to bring Shale Gas Ethane from the US to its petrochemical plants in Scotland and Norway
Astellas Pharma to buy Belgium’s Ogeda for upto $853 mn
03 Apr 2017
Japanese pharmaceutical company Astellas Pharma Inc yesterday struck a deal to buy Belgium-based privately-owned drug discovery firm Ogeda SA
Johnson & Johnson succeeds in $30-bn tender offer for Actelion
31 Mar 2017
J&J had clinched the deal in December after raising its offer to $280 per share or $30 billion in cash, which included spinning off Actelion's research and development pipeline
Silver Lake, Broadcom table $17.9-bn bid for Toshiba’s chip unit
31 Mar 2017
Toshiba is ready to sell a majority stake or even its entire stake in the Nand memory chip unit, its most valuable business, to cover losses from its Westinghouse N-power plant business